These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20865954)

  • 1. Applied for the right reasons, CQI can benefit patients and the ESRD Program.
    Neumann ME
    Nephrol News Issues; 2010 Aug; 24(9):7. PubMed ID: 20865954
    [No Abstract]   [Full Text] [Related]  

  • 2. End-stage renal disease: a proving ground for quality improvement in health care.
    Rutherford WE; Gibney R
    Semin Nephrol; 1997 May; 17(3):218-25. PubMed ID: 9165651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Launching CQI in ESRD: the starting point.
    Hohner G; Sasak C
    Nephrol News Issues; 1995 Nov; 9(11):20-3. PubMed ID: 8538800
    [No Abstract]   [Full Text] [Related]  

  • 4. ESRD quality assessment, assurance, improvement: a retrospective review and a look ahead.
    Burrows-Hudson S; Vlchek D
    Nephrol News Issues; 1997 Feb; 11(2):13-4, 62. PubMed ID: 9096456
    [No Abstract]   [Full Text] [Related]  

  • 5. Palliative care in ESRD.
    Nephrol News Issues; 2003 Feb; 17(3):43-5, 49-50. PubMed ID: 12655998
    [No Abstract]   [Full Text] [Related]  

  • 6. Inching up. Annual sampling of clinical indicators for ESRD patients shows continuing improvement.
    Nephrol News Issues; 2002 Mar; 16(4):13-8. PubMed ID: 11902057
    [No Abstract]   [Full Text] [Related]  

  • 7. Lessons learned. Implementing a vascular access quality improvement program. Part II.
    Duda CR; Spergel LM; Holland J; Tucker CT; Bander SJ; Bosch JP
    Nephrol News Issues; 2000 May; 14(6):29-32, 37. PubMed ID: 11249456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surviving change: Can the ESRD provisions in the SCHIP create a level playing field?
    Gardner AV
    Nephrol News Issues; 2007 Sep; 21(10):52-3. PubMed ID: 17918480
    [No Abstract]   [Full Text] [Related]  

  • 9. [Quality in the treatment of dialysis patients].
    Jung S; Elfrich U
    Krankenpfl Soins Infirm; 1997 Oct; 90(10):24-5. PubMed ID: 9400186
    [No Abstract]   [Full Text] [Related]  

  • 10. RPA's strategy to enhance and improve continuous quality improvement in the ESRD program. Part 2 of 2. Renal Physicians Association.
    Clin Nephrol; 2000 Dec; 54(6):501-2. PubMed ID: 11140813
    [No Abstract]   [Full Text] [Related]  

  • 11. Barriers to the delivery of adequate hemodialysis in ESRD Network 4.
    Palevsky PM; Washington MS; Stevenson JA; Rohay JM; Dyer NJ; Lockett R; Perry SB
    Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S11-20. PubMed ID: 11053582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we revitalize the ESRD program?
    McFeeley T
    Nephrol News Issues; 2004 Apr; 18(5):42-3, 47, 87. PubMed ID: 15125164
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical performance measures report identifies areas for improvement.
    Nephrol News Issues; 2005 Aug; 19(9):30-2. PubMed ID: 16173301
    [No Abstract]   [Full Text] [Related]  

  • 14. Improving compliance with the dialysis prescription as a strategy to increase the delivered dose of hemodialysis: an ESRD Network 4 quality improvement project.
    Palevsky PM; Washington MS; Stevenson JA; Rohay JM; Dyer NJ; Lockett R; Perry SB
    Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S21-30. PubMed ID: 11053583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2005 Annual Report: ESRD Clinical Performance Measures Project.
    ; Kinney R
    Am J Kidney Dis; 2006 Oct; 48(4 Suppl 2):S1-106. PubMed ID: 17045862
    [No Abstract]   [Full Text] [Related]  

  • 16. Using a dialysis "report card" to assess quality.
    Kurtin P
    Nephrol News Issues; 1994 Aug; 8(8):26-7. PubMed ID: 7969548
    [No Abstract]   [Full Text] [Related]  

  • 17. The end stage renal disease program.
    Stark P
    N Engl J Med; 1993 Jul; 329(2):140. PubMed ID: 8510702
    [No Abstract]   [Full Text] [Related]  

  • 18. The direction of end-stage renal disease reimbursement in the United States.
    Lockridge RS
    Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CAN the new K/DOQI guidelines make a difference for the CKD patient.
    Fester S
    Nephrol News Issues; 2002 Apr; 16(5):27, 29. PubMed ID: 11962147
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality assurance for hemodialyzer reprocessing: minimizing risks.
    Taaffe VS
    Nephrol News Issues; 2001 Jun; 15(7):36-9, 41-2. PubMed ID: 12098992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.